OSA and cardiac arrhythmogenesis: mechanistic insights
A surge of data has reproducibly identified strong associations of OSA with cardiac arrhythmias.
As an extension of epidemiologic and clinic-based findings, experimental investigations …
As an extension of epidemiologic and clinic-based findings, experimental investigations …
Evidence-based treatment of anxiety and phobia in children and adolescents: Current status and effects on the emotional response
Research on treatments for childhood anxiety disorders has increased greatly in recent
decades. As a result, it has become increasingly necessary to synthesize the findings of these …
decades. As a result, it has become increasingly necessary to synthesize the findings of these …
[HTML][HTML] Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs
…, NK Aaronson, PB Jacobsen, AM May… - Cancer treatment …, 2017 - Elsevier
This individual patient data meta-analysis aimed to evaluate the effects of exercise on quality
of life (QoL) and physical function (PF) in patients with cancer, and to identify moderator …
of life (QoL) and physical function (PF) in patients with cancer, and to identify moderator …
[HTML][HTML] Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Background The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3 trials. We …
[HTML][HTML] Attributes and predictors of long COVID
Reports of long-lasting coronavirus disease 2019 (COVID-19) symptoms, the so-called ‘long
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …
COVID’, are rising but little is known about prevalence, risk factors or whether it is possible …
[HTML][HTML] Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable
…, K Winters-Stone, J Wiskemann, AM May… - Medicine and science …, 2019 - ncbi.nlm.nih.gov
Purpose: The number of cancer survivors worldwide is growing, with over 15.5 million cancer
survivors in the United States alone–a figure expected to double in the coming decades. …
survivors in the United States alone–a figure expected to double in the coming decades. …
[HTML][HTML] Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based …
…, C Hu, S Selvachandran, L Polidori, A May… - The Lancet Infectious …, 2022 - thelancet.com
Background COVID-19 vaccines show excellent efficacy in clinical trials and effectiveness
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
in real-world data, but some people still become infected with SARS-CoV-2 after vaccination. …
[HTML][HTML] Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance …
Background The SARS-CoV-2 variant of concern, omicron, appears to be less severe than
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
delta. We aim to quantify the differences in symptom prevalence, risk of hospital admission, …
[HTML][HTML] COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study
Background With the surge of new SARS-CoV-2 variants, countries have begun offering
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult population …
COVID-19 vaccine booster doses to high-risk groups and, more recently, to the adult population …
[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
MS Graham, CH Sudre, A May, M Antonelli… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …
England. We aimed to investigate whether increases in the proportion of infections with this …